Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ilgen Mender

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
Journal of Cutaneous Pathology|November 20, 2014
A primary melanoma and its asynchronous metastasis highlight the role of BRAF, CDKN2A, and TERTGregory A Hosler, Teresa Davoli, Ilgen Mender, et al.
Cancer Research|January 18, 2020
<i>SLC43A3</i> Is a Biomarker of Sensitivity to the Telomeric DNA Damage Mediator 6-Thio-2'-DeoxyguanosineIlgen Mender, Kimberly Batten, Michael Peyton, et al.
International Journal of Oncology|April 3, 2013
Imetelstat (a telomerase antagonist) exerts off‑target effects on the cytoskeletonIlgen Mender, Serif Senturk, Nuriman Ozgunes, et al.
Nature Communications|November 9, 2017
A method for measuring the distribution of the shortest telomeres in cells and tissuesTsung-Po Lai, Ning Zhang, Jungsik Noh, et al.
Cancer Cell|July 4, 2020
Telomere Stress Potentiates STING-Dependent Anti-tumor ImmunityIlgen Mender, Anli Zhang, Zhenhua Ren, et al.
Plos Biology|December 16, 2016
Regulation of the Human Telomerase Gene TERT by Telomere Position Effect-Over Long Distances (TPE-OLD): Implications for Aging and CancerWanil Kim, Andrew T Ludlow, Jaewon Min, et al.
Molecular Cancer Therapeutics|April 15, 2018
Induced Telomere Damage to Treat Telomerase Expressing Therapy-Resistant Pediatric Brain TumorsSatarupa Sengupta, Matthew Sobo, Kyungwoo Lee, et al.
Biomolecules|January 8, 2025
A Phosphatidyl Conjugated Telomerase-Dependent Telomere-Targeting Nucleoside Demonstrates Colorectal Cancer Direct Killing and Immune SignalingMerve Yilmaz, Sibel Goksen, Ilgen Mender, et al.
Oncogene|April 27, 2018
Exploiting TERT dependency as a therapeutic strategy for NRAS-mutant melanomaPatricia Reyes-Uribe, Maria Paz Adrianzen-Ruesta, Zhong Deng, et al.
Nature Communications|August 8, 2018
NOVA1 regulates hTERT splicing and cell growth in non-small cell lung cancerAndrew T Ludlow, Mandy Sze Wong, Jerome D Robin, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Journal of Cutaneous Pathology|November 20, 2014
A primary melanoma and its asynchronous metastasis highlight the role of BRAF, CDKN2A, and TERTGregory A Hosler, Teresa Davoli, Ilgen Mender, et al.
Cancer Research|January 18, 2020
<i>SLC43A3</i> Is a Biomarker of Sensitivity to the Telomeric DNA Damage Mediator 6-Thio-2'-DeoxyguanosineIlgen Mender, Kimberly Batten, Michael Peyton, et al.
International Journal of Oncology|April 3, 2013
Imetelstat (a telomerase antagonist) exerts off‑target effects on the cytoskeletonIlgen Mender, Serif Senturk, Nuriman Ozgunes, et al.
Nature Communications|November 9, 2017
A method for measuring the distribution of the shortest telomeres in cells and tissuesTsung-Po Lai, Ning Zhang, Jungsik Noh, et al.
Cancer Cell|July 4, 2020
Telomere Stress Potentiates STING-Dependent Anti-tumor ImmunityIlgen Mender, Anli Zhang, Zhenhua Ren, et al.
Plos Biology|December 16, 2016
Regulation of the Human Telomerase Gene TERT by Telomere Position Effect-Over Long Distances (TPE-OLD): Implications for Aging and CancerWanil Kim, Andrew T Ludlow, Jaewon Min, et al.
Molecular Cancer Therapeutics|April 15, 2018
Induced Telomere Damage to Treat Telomerase Expressing Therapy-Resistant Pediatric Brain TumorsSatarupa Sengupta, Matthew Sobo, Kyungwoo Lee, et al.
Biomolecules|January 8, 2025
A Phosphatidyl Conjugated Telomerase-Dependent Telomere-Targeting Nucleoside Demonstrates Colorectal Cancer Direct Killing and Immune SignalingMerve Yilmaz, Sibel Goksen, Ilgen Mender, et al.
Oncogene|April 27, 2018
Exploiting TERT dependency as a therapeutic strategy for NRAS-mutant melanomaPatricia Reyes-Uribe, Maria Paz Adrianzen-Ruesta, Zhong Deng, et al.
Nature Communications|August 8, 2018
NOVA1 regulates hTERT splicing and cell growth in non-small cell lung cancerAndrew T Ludlow, Mandy Sze Wong, Jerome D Robin, et al.
Pageof 3